Strides Pharma Science shares jump 9% after USFDA EIR for Bengaluru facility
2 sources·Updated August 20, 2026
Covered by 2 sources
- Business Today IN·7h agoStrides Pharma shares jump 10% as Bengaluru facility receives VAI classification
The company said it submitted a comprehensive response within the stipulated timeline, following which the USFDA classified the inspection outcome as Voluntary Action Indicated and issued the Establishment Inspection Report.
Read at Business Today IN → - Economic Times·10h agoStrides Pharma Science shares jump 9% after USFDA EIR for Bengaluru facility
Strides Pharma Science shares rise sharply on Thursday after the USFDA issued an Establishment Inspection Report (EIR) for its Bengaluru facility, concluding a recent cGMP inspection. The inspection ended with five observations, which the company addressed through corrective…
Read at Economic Times →
